Hidehito Horinouchi, Assistant Chief of the National Cancer Center Hospital, shared a post on X:
“New biomarkers for ADCs in lung cancer: the pathologist’s perspective.
Biomarkers for ADC patient selection under development.
Tissue selection and CDx remain key challenges.”
Other articles featuring Hidehito Horinouchi on OncoDaily.